Oct. 2 at 9:41 AM
$URGN UroGen Pharma (URGN) has its main headquarters and administrative facilities in Princeton, New Jersey, USA, at 400 Alexander Park Drive. The company also maintains significant research and development operations in Ra’anana, Israel, where they focus on innovation for their pipeline and RTGel drug delivery technology. For commercial drug manufacturing, UroGen utilizes contract manufacturing organizations (CMOs), predominantly in the United States, but the company's R&D and technical operations are notably split between the U.S. and Israel.
